Deutsch | English | Français - CHF | EUR | USD
Analyses | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
 Vous vous trouvez dans - Home - Information professionnelle sur Amlodipin Pfizer®
Information professionnelle sur Amlodipin Pfizer®:Pfizer AG
Information professionnelle complèteDDDimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour
C08CA01 - AmlodipineATC-DDD Version 2012. Source: WHO
C - Cardiovascular System
 
C08 - Calcium Channel Blockers

The calcium channel blockers are classified according to selectivity of calcium channel activity and direct cardiac effects. The ATC 4th levels are subdivided according to chemical structure.
Combinations with ergot alkaloids (C04AE) are classified in this group by using the 50-series.
Combinations with diuretics are classified in C08G.
Combinations with ACE inhibitors are classified in C09BB.
Combinations with beta blocking agents are classified in C07F.

The DDDs for calcium channel blockers are based on the treatment of mild-moderate hypertension, although some are used for other indications (e.g. angina pectoris).
The DDDs for oral and parenteral preparations are equal and are based on the oral dose, since oral preparations represent the major fraction of the total consumption.

C08C - Selective Calcium Channel Blockers with Mainly Vascular Effects
 
C08CA - Dihydropyridine Derivatives

Preparations containing nifedipine in combination with ergot alkaloids are classified in C08CA55.
Combinations with diuretics are classified in C08G.
Amlodipine in combination with atorvastatin is classified in C10BX03.

C08CA01 - Amlodipine
Concentr.Adm.RouteNote
5 mgO 
LGPL2013 ywesee.com, Commit-ID
Einstellungen | Aide | FAQ | Identification | Contact | Home